At some point everyone will need to accept some pesky facts.
1. CGM technology is still in it’s infancy and hasn’t come close to it’s full potential.
2. Insulin using patients or should we say highly engaged patients are the low hanging fruit for CGM.
3. Now that we have two systems that are very patient friendly, i.e. no calibration, simple painless insertion and longer sensor life there is no need to do the hippy hippy for incremental improvements in the systems.
4. More systems will flood this market as they see what we do the . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.